Interv Akut Kardiol. 2017;16(4):142-145 | DOI: 10.36290/kar.2017.023

Plasma sCD163 levels in patients with ST-elevation myocardial infarction

Radek Pudil1, Lucie Horáková1, Ctirad Andrýs2, Josef ©»ásek1
1 I. interní kardioangiologická klinika, LF UK a FN Hradec Králové
2 Ústav klinické imunologie a alergologie, LF UK a FN Hradec Králové

Background: The ischemia/reperfusion process in the course of acute coronary syndrome with ST-segment elevation is associatedwith significant increase of immune system activation. CD163 molecule belongs to important parts of the scavenger system,which helps to eliminate hemoglobin-haptoglobin complex and has the potential to suppress reactive oxygen radicals production.

Aim: The aim of our study was to assess sCD163 level in the course of STEMI.Patients and method: Plasma sDC163 level was assessed in a group of 29 patients (25 males, 4 females) of average age 64.5 let± 7.5 yrs. at the time of admission, at 24 hours and at 96 hours.

Results: The plasma sCD163 level was increasing during the time of observation [0h: 1770.5 (1451; 2096.25) μg/L vs. 1178 (1078;1265) μg/L, p < 0.001, 24h: 2063 (1589; 2453) vs. 1178 (1078;1265) μg/L, p < 0.001, 96h: 2116 (1924; 2458) vs. 1178 (1078; 1265) μg/L, p < 0.001]. Plasma sCD163 level was associated with leftventricle ejection fraction.

Conclusion: The study showed a potential significance of sCD163 assessment as a prognostic marker.

Keywords: ST-elevation myocardial infarction, humoral immunity, reperfusion, soluble CD163

Received: November 14, 2017; Accepted: December 14, 2017; Published: December 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pudil R, Horáková L, Andrýs C, ©»ásek J. Plasma sCD163 levels in patients with ST-elevation myocardial infarction. Interv Akut Kardiol. 2017;16(4):142-145. doi: 10.36290/kar.2017.023.
Download citation

References

  1. Fabriek BO, Dijkstra CD, van den Berg TK. The macrophage scavenger receptor CD163. Immunobiology 2005; 210: 153-60. Go to original source... Go to PubMed...
  2. Fabriek BO, van Bruggen R, Deng DM, et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009; 113: 887-92. Go to original source...
  3. Krieger M. The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol 1997; 8: 275-280. Go to original source... Go to PubMed...
  4. Van den Heuvel MM, Tensen CP, van As JH, et al. Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation. J Leukoc Biol 1999; 66: 858-866. Go to original source... Go to PubMed...
  5. Gronlund J, Vitved L, Lausen M, Skjodt K, Holmskov U. Cloning of a novel scavenger receptor cysteine-rich type I transmembrane molecule (M160) expressed by human macrophages. J Immunol 2000; 165: 6406-6415. Go to original source... Go to PubMed...
  6. Stöger JL, Gijbels MJ, van der Velden S et al. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 2012; 225(2): 461-468. Go to original source... Go to PubMed...
  7. Finn AV, Nakano M, Polavarapu R, et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J Am Coll Cardiol 2012; 59(2): 166-177. Go to original source...
  8. de Gaetano M, Crean D, Barry M, Belton O. M1- and M2-Type Macrophage Responses Are Predictive of Adverse Outcomes in Human Atherosclerosis. Front Immunol. 2016; 7:275. doi: 10.3389/fimmu.2016.00275. Go to original source... Go to PubMed...
  9. Sato T, Kameyama T, Noto T, et al. The impact of anti-inflammatory cytokines provoked by CD163 positive macrophages on ventricular functional recovery after myocardial infarction J Thromb Thrombolysis 2014; 37: 139. https://doi.org/10.1007/s11239-013-0971-3.) Go to original source... Go to PubMed...
  10. Willemsen HM, van der Horst IC, Nieuwland W, Slart RJ, Zeebregts CJ, de Boef E, Schuitemaker JH, Zijlstra F, Tio RA. The diagnostic value of soluble CD163 in patients presenting with chest pain. Clin Biochem 2009; 42(16-17): 1662-6. doi: 10.1016/j.clinbiochem.2009.06.028. Go to original source...
  11. Buechler C, Eisinger K, Krautbauer S. Diagnostic and prognostic potential of the macrophage specific receptor CD163 in inflammatory diseases. Inflamm Allergy Drug Targets 2013; 12(6): 391-402. Go to original source...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.